Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
599 ARTÍCULOS , VIENDO DEL 436 AL 450
Generalized chorea associated with subcortical leukoaraiosis of Binswanger type: a case report
Espiritu AI, Saranza GRM, Anlacan VMM, Suratos CTR, Jamora RDG.
Neurodegener Dis Manag. 2020 Feb;10(1):9-13. doi: 10.2217/nmt-2019-0021. Epub 2020 Feb 6.
Simultaneous Occurrence of Sydenham Chorea with Erythema Marginatum: A Case of Rheumatic Fever
Tsega Desta T, Naizgi M.
Pediatric Health Med Ther. 2020 Feb 18;11:55-58. doi: 10.2147/PHMT.S229254. eCollection 2020.
Waddington JL.
Acta Pharmacol Sin. 2020 Apr;41(4):464-470. doi: 10.1038/s41401-020-0373-y. Epub 2020 Mar 5.
Hyperglycaemic chorea-ballism or unmasking of Huntington's chorea in a patient with diabetes
Yelam A, Nagarajan E, Digala LP, Bollu PC.
BMJ Case Rep. 2020 Mar 17;13(3):e232726. doi: 10.1136/bcr-2019-232726.
Chorea and Parkinsonism with Elevated Striational Antibody
Gupta HV, Barnes H, Radhi FA, Jassam Y.
Ann Indian Acad Neurol. 2020 Mar-Apr;23(2):223-224. doi: 10.4103/aian.AIAN_364_19. Epub 2020 Feb 25.
Chorea as the First Manifestation of Cerebral Infarction
Hernandez Fustes OJ, Puppi Munhoz R, Arteaga Rodriguez C, Hernandez Fustes OJ.
Cureus. 2020 Mar 24;12(3):e7384. doi: 10.7759/cureus.7384.
Voluntary Inhibitory Control of Chorea: A Case Series
Bonomo R, Latorre A, Balint B, Smilowska K, Rocchi L, Rothwell JC, Zappia M, Bhatia KP.
Mov Disord Clin Pract. 2020 Feb 20;7(3):308-312. doi: 10.1002/mdc3.12907. eCollection 2020 Apr.
How have advances in genetic technology modified movement disorder nosology?
Sturchio A, Marsili L, Mahajan A, Grimberg MB, Kauffman MA, Espay AJ.
Eur J Neurol. 2020 Aug;27(8):1461-1470. doi: 10.1111/ene.14294. Epub 2020 May 31.
ACR Appropriateness Criteria® Movement Disorders and Neurodegenerative Diseases
Expert Panel on Neurological Imaging; Harvey HB, Watson LC, Subramaniam RM, Burns J, Bykowski J, Chakraborty S, Ledbetter LN, Lee RK, Pannell JS, Pollock JM, Powers WJ, Rosenow JM, Shih RY, Slavin K, Utukuri PS, Corey AS.
J Am Coll Radiol. 2020 May;17(5S):S175-S187. doi: 10.1016/j.jacr.2020.01.042.
Optic Atrophy and Generalized Chorea in a Patient Harboring an OPA10/RTN4IP1 Pathogenic Variant
Giacomini T, Gamucci A, Pisciotta L, Nesti C, Fiorillo C, Doccini S, Morana G, Nobili L, Santorelli FM, Mancardi MM, De Grandis E.
Neuropediatrics. 2020 Dec;51(6):425-429. doi: 10.1055/s-0040-1708539. Epub 2020 May 11.
Dysregulated Brain Cholesterol Metabolism Is Linked to Neuroinflammation in Huntington's Disease
González-Guevara E, Cárdenas G, Pérez-Severiano F, Martínez-Lazcano JC.
Mov Disord. 2020 Jul;35(7):1113-1127. doi: 10.1002/mds.28089. Epub 2020 May 15.
VMAT2 inhibitors for the treatment of hyperkinetic movement disorders
Koch J, Shi WX, Dashtipour K.
Pharmacol Ther. 2020 Aug;212:107580. doi: 10.1016/j.pharmthera.2020.107580. Epub 2020 May 23.
A Critical Review of White Matter Changes in Huntington's Disease
Casella C, Lipp I, Rosser A, Jones DK, Metzler-Baddeley C.
Mov Disord. 2020 Aug;35(8):1302-1311. doi: 10.1002/mds.28109. Epub 2020 Jun 15.
Maximizing placebo response in neurological clinical practice
Mariani LL, Corvol JC.
Int Rev Neurobiol. 2020;153:71-101. doi: 10.1016/bs.irn.2020.04.003. Epub 2020 Jun 9.
[ADCY5-associated dyskinesia in young children: a case report of a family and an updated review]
Aguilera-Nieto L, Ferrero-Turrión J, Mora-Ramírez MD, Calvo-Medina R, Ruiz-García C, Ramos-Fernández JM.
Rev Neurol. 2020 Jul 16;71(2):69-73. doi: 10.33588/rn.7102.2020154.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.